Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HLF Stock Forecast 2026-2027
$15.17
Current Price
$1.57B
Market Cap
Buy 3
Hold 1
Sell 1
Wall St Analyst Ratings
Distance to HLF Price Targets
+64.8%
To High Target of $25.00
+5.5%
To Median Target of $16.00
-40.7%
To Low Target of $9.00
HLF Price Momentum
+9.2%
1 Week Change
-7.4%
1 Month Change
+123.7%
1 Year Change
+17.7%
Year-to-Date Change
-25.6%
From 52W High of $20.40
+144.7%
From 52W Low of $6.20
📊 TOP ANALYST CALLS
Did HLF Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Herbalife is one of their latest high-conviction picks.
Latest HLF Stock Price Targets & Analyst Predictions
Based on our analysis of 11 Wall Street analysts, HLF has a bullish consensus with a median price target of $16.00 (ranging from $9.00 to $25.00). The overall analyst rating is Buy (7.6/10). Currently trading at $15.17, the median forecast implies a 5.5% upside. This outlook is supported by 3 Buy, 1 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by John Baumgartner at Mizuho, suggesting a 40.7% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HLF Analyst Ratings
3
Buy
1
Hold
1
Sell
HLF Price Target Range
Low
$9.00
Average
$16.00
High
$25.00
Current: $15.17
Latest HLF Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HLF.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 30, 2026 | Mizuho | John Baumgartner | Neutral | Maintains | $15.00 |
| Feb 19, 2026 | Citigroup | Chasen Bender | Buy | Maintains | $21.00 |
| Jan 8, 2026 | Mizuho | John Baumgartner | Neutral | Maintains | $13.00 |
| Jan 6, 2026 | Maxim Group | Anthony Vendetti | Buy | Initiates | $20.00 |
| Dec 12, 2025 | Citigroup | Chasen Bender | Buy | Maintains | $17.00 |
| Nov 26, 2025 | Argus Research | John Staszak | Buy | Upgrade | $N/A |
| Nov 26, 2025 | Mizuho | John Baumgartner | Neutral | Maintains | $11.00 |
| Jul 28, 2025 | Mizuho | John Baumgartner | Neutral | Maintains | $9.00 |
| May 1, 2025 | Citigroup | Chasen Bender | Buy | Maintains | $11.00 |
| Mar 21, 2025 | DA Davidson | Linda Bolton Weiser | Buy | Upgrade | $14.00 |
| Feb 20, 2025 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $7.50 |
| Nov 1, 2024 | Mizuho | John Baumgartner | Neutral | Maintains | $9.00 |
| Oct 31, 2024 | B. Riley Securities | Jeff Van Sinderen | Buy | Maintains | $12.00 |
| Oct 31, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $7.50 |
| Oct 25, 2024 | Citigroup | Chasen Bender | Buy | Maintains | $13.00 |
| Aug 1, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $13.00 |
| Aug 1, 2024 | B. Riley Securities | Jeff Van Sinderen | Buy | Maintains | $17.00 |
| Jun 7, 2024 | Mizuho | John Baumgartner | Neutral | Maintains | $11.00 |
| May 2, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $9.50 |
| Mar 25, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $9.50 |
Herbalife Ltd. (HLF) Competitors
The following stocks are similar to Herbalife based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Herbalife Ltd. (HLF) Financial Data
Herbalife Ltd. has a market capitalization of $1.57B with a P/E ratio of 6.9x. The company generates $5.04B in trailing twelve-month revenue with a 4.5% profit margin.
Revenue growth is +6.3% quarter-over-quarter, while maintaining an operating margin of +8.3% and return on equity of -44.8%.
Valuation Metrics
Market Cap
$1.57B
Enterprise Value
$3.40B
P/E Ratio
6.9x
PEG Ratio
-0.1x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
+6.3%
Gross Margin
+77.5%
Operating Margin
+8.3%
Net Margin
+4.5%
EPS Growth
-52.0%
Financial Health
Cash/Price Ratio
+22.5%
Current Ratio
1.1x
Debt/Equity
-4.3x
ROE
-44.8%
ROA
+11.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Herbalife Ltd. (HLF) Business Model
About Herbalife Ltd.
What They Do
Nutritional supplements and personal care products provider.
Business Model
Herbalife operates a direct-selling business model, allowing independent distributors to market and sell its nutritional and personal care products. The company generates revenue through product sales, leveraging a vast network of distributors who earn commissions based on their sales and recruitment efforts.
Additional Information
Founded in 1980, Herbalife is present in over 90 countries and emphasizes research and development along with personalized customer service. It plays a significant role in the global health and wellness industry, influencing trends in diet, weight management, fitness, and skin care.
Company Information
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
8,600
CEO
Mr. Stephan Paulo Gratziani
Country
United States
IPO Year
2004
Website
www.herbalife.comHerbalife Ltd. (HLF) Latest News & Analysis
Latest News
Quick Summary
Herbalife Ltd. (NYSE: HLF) will release Q1 2026 financial results on May 6, 2026, after market close, followed by a conference call at 5:30 p.m. ET. Webcast details available online.
Why It Matters
Herbalife's upcoming financial results and conference call can impact stock performance by influencing investor sentiment, expectations for growth, and market positioning within the health and wellness sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zacks Premium research service offers Zacks Style Scores, aiding value, growth, and momentum investors in identifying strong stocks more effectively.
Why It Matters
The Zacks Style Scores can help investors identify strong stocks more effectively, enhancing their investment strategies and potential returns across different investment styles.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Herbalife Ltd. (NYSE: HLF) announced an agreement to acquire assets from UK-based Bioniq, enhancing its data-driven health and wellness platform.
Why It Matters
Herbalife's acquisition of Bioniq enhances its technology-driven strategy, potentially increasing market share and revenue in the growing personalized health sector, appealing to health-conscious consumers.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zacks emphasizes its Rank system that highlights earnings estimates and revisions to identify strong stocks, while also monitoring trends in value, growth, and momentum.
Why It Matters
Zacks' emphasis on earnings estimates and revisions highlights potential stock performance, offering investors insights into promising growth, value, and momentum opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores help investors identify top-rated stocks aligned with their investing style, providing a useful tool for stock selection.
Why It Matters
Zacks Style Scores provide a systematic approach to identify high-potential stocks, aiding investors in making informed decisions aligned with their investment strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Herbalife Ltd (HLF) and J.Jill (JILL) have shown performance metrics for 2023, relative to their respective sectors. Detailed figures were not provided in the excerpt.
Why It Matters
Performance comparisons reveal how HLF and JILL are faring relative to their sector, indicating potential investment opportunities or risks based on market trends and competitive positioning.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About HLF Stock
What is Herbalife Ltd.'s (HLF) stock forecast for 2026?
Based on our analysis of 11 Wall Street analysts, Herbalife Ltd. (HLF) has a median price target of $16.00. The highest price target is $25.00 and the lowest is $9.00.
Is HLF stock a good investment in 2026?
According to current analyst ratings, HLF has 3 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $15.17. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HLF stock?
Wall Street analysts predict HLF stock could reach $16.00 in the next 12 months. This represents a 5.5% increase from the current price of $15.17. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Herbalife Ltd.'s business model?
Herbalife operates a direct-selling business model, allowing independent distributors to market and sell its nutritional and personal care products. The company generates revenue through product sales, leveraging a vast network of distributors who earn commissions based on their sales and recruitment efforts.
What is the highest forecasted price for HLF Herbalife Ltd.?
The highest price target for HLF is $25.00 from at , which represents a 64.8% increase from the current price of $15.17.
What is the lowest forecasted price for HLF Herbalife Ltd.?
The lowest price target for HLF is $9.00 from John Baumgartner at Mizuho, which represents a -40.7% decrease from the current price of $15.17.
What is the overall HLF consensus from analysts for Herbalife Ltd.?
The overall analyst consensus for HLF is bullish. Out of 11 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 1 as Sell, with a median price target of $16.00.
How accurate are HLF stock price projections?
Stock price projections, including those for Herbalife Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 10, 2026 8:49 AM UTC